Skip to content

The effect of curcumin supplementation with High-intensity interval training on serum Irisin levels and lipid profile in non-active obese women "

The effect of curcumin supplementation with High-intensity interval training on serum Irisin levels and lipid profile in non-active obese women: a randomized clinical trial "

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141004019397N2
Enrollment
40
Registered
2021-09-10
Start date
2021-07-16
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity women. Overweight and obesity

Interventions

Intervention 1: Intervention group: The curcumin supplement group will take one 80 mg nanomicillin curcumin capsule daily for eight weeks before lunch with a glass of water. Intervention 2: Interventi

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 35 Years

Inclusion criteria

Inclusion criteria: Women aged 30 to 35 years, obese (BMI greater or equal to 30), lack of regular exercise during the last two years, an impaired lipid profile, not taking drugs and supplements

Exclusion criteria

Exclusion criteria: Having thyroid, cardiovascular, respiratory, hypertension, diabetes, metabolic syndrome, pregnancy and lactation as well as allergies to spices unwillingness to cooperate

Design outcomes

Primary

MeasureTime frame
The rate of change in plasma aerosin. Timepoint: At baseline and two days after the last training session. Method of measurement: Sunlong Biotech kits will be used to measure aerosin.;Lipid profile changes. Timepoint: At baseline and two days after the last training session. Method of measurement: To measure lipid profile, it will be measured from Pars-Azmoon kits by ELISA method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahram Jamali

Tabriz University of Medical Sciences

jamalib@tbzmed.ac.ir+98 41 3336 1900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026